Press Releases :: Axogen, Inc. (AXGN)

Year

Category

Dec 6, 2023 7:00 am EST

Axogen Announces Transition of Finance Team Leadership

Dec 1, 2023 5:00 pm EST

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nov 20, 2023 7:00 am EST

Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference

Nov 7, 2023 7:00 am EST

Axogen, Inc. Reports 2023 Third Quarter Financial Results

Oct 18, 2023 7:00 am EDT

Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023

Sep 5, 2023 7:00 am EDT

Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™

Aug 31, 2023 7:00 am EDT

Axogen to Participate at Upcoming Investor Conferences

Aug 21, 2023 7:00 am EDT

Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio

Aug 7, 2023 4:01 pm EDT

Axogen, Inc. Reports 2023 Second Quarter Financial Results

Jul 27, 2023 7:00 am EDT

Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference